Development Level

Tbio 3 | 10,625
Tclin 3 | 602

IMPC Term

decreased leukocyte cell numbe... 1 | 54

Disease

Cancer 6 | 2,346
Diarrhea 4 | 155
invasive ductal carcinoma 4 | 2,950
lung cancer 4 | 4,466
Breast cancer 3 | 3,094
Exanthem 3 | 39
Human immunodeficiency virus infectious disease 3 | 92
Hypersensitivity reaction type II disease 3 | 235
Liver disease 3 | 219
Mammary Neoplasms 3 | 410
Neutropenia 3 | 78
Rheumatoid Arthritis 3 | 1,160
diabetes mellitus 3 | 1,663
ductal carcinoma in situ 3 | 1,745
interstitial cystitis 3 | 2,299
medulloblastoma 3 | 1,524
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Adenocarcinoma 2 | 115
Adenocarcinoma of lung (disorder) 2 | 48
Adenoma 2 | 165
Adult T-Cell Lymphoma/Leukemia 2 | 30
Allergic hypersensitivity disease 2 | 123
Animal Mammary Neoplasms 2 | 136
Asthma 2 | 349
Atherosclerosis 2 | 275
Atopic dermatitis 2 | 944
Breast fibroadenoma 2 | 8
Carcinoma 2 | 2,147
Cholangiocarcinoma 2 | 32
Colonic Neoplasms 2 | 126
Dermatitis 2 | 107
Diabetes Mellitus, Insulin-Dependent 2 | 76
Disease Progression 2 | 125
Esophageal Neoplasms 2 | 67
Glioma 2 | 65
HER2 Positive Carcinoma of Breast 2 | 2
Heart disease 2 | 279
Hepatitis B 2 | 103
Kidney cancer 2 | 118
Kidney disease 2 | 396
Lung Neoplasms 2 | 171
Mammary Neoplasms, Experimental 2 | 150
Multiple Sclerosis 2 | 498
Neoplasm Metastasis 2 | 138
Neoplasm Recurrence, Local 2 | 23
Neuropathy 2 | 210
Non-small cell lung cancer, positive for epidermal growth factor receptor expression 2 | 4
Papilloma 2 | 27
Peripheral Neuropathy 2 | 303
Prostatic Neoplasms 2 | 471
Severe Combined Immunodeficiency 2 | 46
Stomach Neoplasms 2 | 282
Stomatitis 2 | 19
Thrombocytopenia 2 | 105
Type 1 diabetes mellitus 2 | 101
Uveitis 2 | 103
Vasculitis 2 | 64
adult high grade glioma 2 | 2,148
atypical teratoid / rhabdoid tumor 2 | 4,369
breast carcinoma 2 | 1,614
cutaneous lupus erythematosus 2 | 1,056
gallbladder neoplasm 2 | 9
glioblastoma 2 | 5,572
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
non-small cell lung carcinoma 2 | 413
oligodendroglioma 2 | 2,849
ovarian neoplasm 2 | 97
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
sarcoidosis 2 | 358
ulcerative colitis 2 | 2,087
Arthritis, Experimental 1 | 39
Autoimmune thyroiditis 1 | 24
Brain cancer 1 | 21
Breast disease 1 | 8
Carcinoma of thyroid 1 | 17
Cavernous hemangioma 1 | 12
Celiac disease 1 | 112
Chloracne 1 | 32
Comedo carcinoma 1 | 2
Connective tissue disease 1 | 59
DOID:2627 1 | 14
Esophageal atresia 1 | 25
Gastritis 1 | 44
HER2-positive carcinoma of breast 1 | 10
Head and Neck Neoplasms 1 | 23
Hemangioma 1 | 35
Leiomyoma 1 | 25
Lobular neoplasia 1 | 15
Lymphoma, T-Cell, Cutaneous 1 | 21
Malignant glioma 1 | 23
Neoplasm Invasiveness 1 | 127
Neoplastic Cell Transformation 1 | 81
Otosclerosis 1 | 13
Paronychia 1 | 7
Primary immunodeficiency disease 1 | 52
Skin disease 1 | 65
Squamous cell carcinoma of the head and neck 1 | 24

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 3 | 11,971
Kinase 2 | 634
Transcription Factor 1 | 1,400

Grant Application

1R01CA184199-01 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Forkhead box protein P3 FOXP3 Tbio Transcription Factor -3.60057 5680.3 1162
Hematopoietic progenitor cell antigen CD34 CD34 Tbio Non-IDG -4.11691 13305.6 1625
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.46843 3564.0 656
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.22922 19000.3 3336
Epidermal growth factor receptor EGFR Tclin Kinase -3.95948 9318.1 4989
Noggin NOG Tbio Non-IDG -2.88693 783.1 315